(b)(4) patient identifier: (b)(6).The device remains implanted; therefore, no further investigation can be performed.A manufacturing record evaluation was performed for the finished device 30550293 number, and no non-conformances related to the malfunction were identified.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.The company is seeking this information through the event investigation.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.This report is being submitted pursuant to the provisions of 21 cfr, part 4.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.This is one of four products involved with the complaint and the associated manufacturer report numbers are 3008114965-2021-00670, 3008114965-2021-00671, 3008114965-2021-00672.
|
As reported by the sterling study, a (b)(6) female ((b)(6)) with a history of active smoking and intracranial aneurysm underwent coil embolization of an unruptured left posterior communicating artery aneurysm on (b)(6) 2021 and experienced intraoperative aneurysm perforation.Balloon occlusion was performed as intervention, and the event required prolonged hospitalization.The patient is recovering from the event.The event was classified as severe.Per the principal investigator (pi), the event was related to the study device.The event was considered serious.
|